Synthetic ligands of the vitamin D receptor that target the TGF-β-SMAD signaling pathway, which is known to regulate fibrosis-associated gene expression, ameliorated renal fibrosis in two different mouse models [110]. This evidence concerns the gene TGFB1 and renal fibrosis.